This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Estia Health Gestion

Gestion contrôle des critères 2/4

Le PDG Estia Health's est Sean Bilton, nommé en Jul2022, a un mandat de 1.42 ans. La rémunération annuelle totale est A$ 1.31M, composée du salaire de 54.4% et des bonus 45.6%, y compris les actions et options de la société. détient directement 0.43% des actions de la société, d'une valeur de A$ 3.44M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 1.7 ans et 6.4 ans.

Informations clés

Sean Bilton

Directeur général

AU$1.3m

Rémunération totale

Pourcentage du salaire du PDG	54.4%
Durée du mandat du directeur général	1.4yrs
Propriété du PDG	0.4%
Durée moyenne d'occupation des postes de direction	1.7yrs
Durée moyenne du mandat des membres du conseil d'administration	6.4yrs

Mises à jour récentes de la gestion

Recent updates

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

Feb 25

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Nov 04

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Apr 13

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Mar 08

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Feb 21

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Jan 24

Analyse de la rémunération des PDG

Comment la rémunération de Sean Bilton a-t-elle évolué par rapport aux bénéfices de Estia Health?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2023	AU$1m	AU$709k	-AU$34m
Mar 31 2023	n/a	n/a	-AU$52m
Dec 31 2022	n/a	n/a	-AU$70m
Sep 30 2022	n/a	n/a	-AU$61m
Jun 30 2022	AU$905k	AU$496k	-AU$52m
Mar 31 2022	n/a	n/a	-AU$25m
Dec 31 2021	n/a	n/a	AU$3m
Sep 30 2021	n/a	n/a	AU$4m
Jun 30 2021	AU$640k	AU$478k	AU$6m
Mar 31 2021	n/a	n/a	-AU$66m
Dec 31 2020	n/a	n/a	-AU$137m
Sep 30 2020	n/a	n/a	-AU$127m
Jun 30 2020	AU$551k	AU$479k	-AU$117m
Mar 31 2020	n/a	n/a	-AU$41m
Dec 31 2019	n/a	n/a	AU$35m
Sep 30 2019	n/a	n/a	AU$38m
Jun 30 2019	AU$760k	AU$331k	AU$41m

Rémunération vs marché: La rémunération totale de Sean ($USD 882.91K ) est dans la moyenne des entreprises de taille similaire sur le marché Australian ($USD 838.87K ).

Rémunération et revenus: La rémunération de Sean a augmenté alors que l'entreprise n'est pas rentable.

PDG

Sean Bilton

1.4yrs

Titularisation

AU$1,305,208

Compensation

Mr. Sean Bilton serves as Chief Executive Officer, Managing Director and Director of Estia Health Limited since July 11 2022. He was Chief Operating Officer at Estia Health Limited since October 23, 2018 u...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Sean Bilton	CEO, MD & Director	1.4yrs	AU$1.31m	0.43% A$ 3.4m
Damian Hiser	Chief Operating Officer	1.4yrs	AU$800.07k	0.044% A$ 354.6k
Anthony Rice	Chief Financial Officer	less than a year	pas de données	pas de données
Fiona Caldwell	Chief Information Officer	6.2yrs	pas de données	pas de données
Suzy Watson	General Counsel & Chief Privacy Officer	9.2yrs	pas de données	pas de données
Cath Gillard	Chief People Officer	1.6yrs	pas de données	pas de données
Leanne Laidler	Chief Quality & Risk Officer	4.6yrs	pas de données	pas de données
Michael Lockwood	Chief Development & Property Officer	1.7yrs	pas de données	pas de données
Leanne Ralph	Company Secretary	4.7yrs	pas de données	pas de données

1.7yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de EHE n'est pas considérée comme expérimentée (ancienneté moyenne 1.7 ans), ce qui suggère une nouvelle équipe.

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Sean Bilton	CEO, MD & Director	1.4yrs	AU$1.31m	0.43% A$ 3.4m
Paul Foster	Independent Non-Executive Director	7.8yrs	AU$145.00k	0.0092% A$ 73.9k
Gary Weiss	Independent Non-Executive Chairman	7.8yrs	AU$280.00k	0.040% A$ 318.2k
Norah Barlow	Independent Non-Executive Director	9.1yrs	AU$125.00k	0.050% A$ 398.7k
Helen Kurincic	Independent Non-Executive Director	6.4yrs	AU$145.00k	0.019% A$ 154.0k
Karen Lee Penrose	Independent Non-Executive Director	5.2yrs	AU$135.00k	0.017% A$ 135.7k
Simon Willcock	Independent Non-executive Director	1.3yrs	AU$100.00k	pas de données

6.4yrs

Durée moyenne de l'emploi

64.5yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de EHE sont considérés comme expérimentés (ancienneté moyenne 6.4 ans).

This company listing is no longer active

Estia Health Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Independent Non-Executive Chairman recently bought AU$52k worth of stock

CEO, MD & Director recently bought AU$106k worth of stock

Estia Health Limited Announces Retirement of Mr. Steve Lemlin, Chief Financial Officer

Estia Health Limited, Annual General Meeting, Nov 03, 2022

Estia Health Limited Announces Appointment of Simon Willcock as Non-Executive Director Effective 1 September 2022

Recent updates

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Consensus EPS estimates fall by 30%, revenue upgraded

New minor risk - Dividend sustainability

Estia Health Limited Announces Dividend, Payable on September 15, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 16%

Estia Health Limited (ASX:EHE) entered into a binding agreement to acquire residential aged care homes in Benalla of Royal Freemasons Ltd.

Estia Health Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Bain Capital Reportedly Moves to Sell Craigcare But Abandons Its Pursuit of Estia

Consensus EPS estimates fall by 15%

Price target increased by 12% to AU$2.83

Independent Non-Executive Chairman recently bought AU$52k worth of stock

Consensus EPS estimates fall by 22%, revenue upgraded

First half 2023 earnings released: AU$0.098 loss per share (vs AU$0.031 loss in 1H 2022)

Estia Health Limited to Report First Half, 2023 Results on Feb 21, 2023

CEO, MD & Director recently bought AU$106k worth of stock

Consensus forecasts updated

Estia Health Limited Announces Retirement of Mr. Steve Lemlin, Chief Financial Officer

Consensus estimates of losses per share improve by 51%

Estia Health Limited, Annual General Meeting, Nov 03, 2022

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Estia Health Limited Announces Appointment of Simon Willcock as Non-Executive Director Effective 1 September 2022

Estia Health Limited Appoints Sean Bilton as Director

Estia Health Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Consensus forecasts updated

Insufficient new directors

Estia Health Limited Announces Management Changes

Estia Health Limited announces resignation of Hon. Warwick L. Smith AO as director, effective 31 March 2022

Consensus forecasts updated

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

First half 2022 earnings: EPS misses analyst expectations

Estia Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022

Consensus forecasts updated

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Insufficient new directors

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.45 loss in FY 2020)

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Price target increased to AU$2.15

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Price target raised to AU$1.94

First half 2021 earnings released: AU$0.02 loss per share (vs AU$0.055 profit in 1H 2020)

Estia Health Limited Not Declare Interim Dividend for the Six Months Ended December 31, 2020

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Estia Health Limited Reaches an Agreement to Settle the Shareholder Class Action Commenced Against It in July 2019

New 90-day high: AU$1.96

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Is Estia Health (ASX:EHE) Using Too Much Debt?

Estia Health Limited to Report Q2, 2021 Results on Feb 23, 2021

Have Insiders Been Buying Estia Health Limited (ASX:EHE) Shares?

New 90-day high: AU$1.63

New 90-day low: AU$1.36

New 90-day low: AU$1.37

Non-Executive Director recently bought AU$101k worth of stock

Price target lowered to AU$1.62

Earnings released

Estia Health Limited Determines Not to Declare A Final Dividend for Fiscal Year 2020

Did Estia Health Limited (ASX:EHE) Insiders Buy Up More Shares?

Is There Now An Opportunity In Estia Health Limited (ASX:EHE)?

Estia Health Limited(ASX:EHE) dropped from S&P/ASX 200 Index

Analyse de la rémunération des PDG

PDG

Titularisation

Compensation

Équipe de direction

Durée moyenne de l'emploi

Membres du conseil d'administration

Durée moyenne de l'emploi

Âge moyen